Human Gene Therapy: A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response

https://www.liebertpub.com/toc/hum/0/0?utm_campaign=HUM+FP+January+4%2C+2024+AD&utm_content=CTA-Button&utm_term=&utm_medium=email&utm_source=Adestra